Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 6/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 1.00 |
| ▸ | MEN1 | O00255 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | AGTR1 | P30556 | 2/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | CXCR2 | P25025 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | CKS1B | P61024 | 4/20 | 0.85 |
| ▸ | SKP2 | Q13309 | 4/20 | 0.85 |
| ▸ | SLC40A1 | Q9NP59 | 10/20 | 0.82 |
| ▸ | POLB | P06746 | 1/20 | 0.79 |
| ▸ | NFKBIA | P25963 | 3/20 | 0.71 |
| ▸ | RELA | Q04206 | 2/20 | 0.71 |
| ▸ | MITF | O75030 | 1/20 | 0.67 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1505430 | 1.00 | KMT2A (1.00) | KMT2ATDP1MEN1LMNAMAPT | |
| SCHEMBL13633886 | 0.93 | MEN1 (1.00) | KMT2ATDP1MEN1LMNAMAPT | |
| SCHEMBL17506531 | 0.92 | CKS1B (1.00) | KMT2ATDP1MEN1LMNAMAPT | |
| SCHEMBL7197593 | 0.90 | SLC40A1 (1.00) | KMT2ATDP1MEN1LMNAMAPT | |
| SCHEMBL4489851 | 0.89 | MEN1 (0.84) | KMT2ATDP1MEN1LMNAMAPT | |
| SCHEMBL22111633 | 0.89 | MEN1 (0.84) | KMT2ATDP1MEN1LMNAMAPT | |
| SCHEMBL17506539 | 0.88 | KMT2A (0.79) | KMT2ATDP1MEN1LMNAMAPT | |
| SCHEMBL22076984 | 0.88 | MEN1 (1.00) | KMT2ATDP1MEN1LMNAMAPT | |
| SCHEMBL4472564 | 0.86 | MEN1 (0.79) | KMT2ATDP1MEN1LMNAMAPT | |
| SCHEMBL6688368 | 0.86 | SLC40A1 (0.85) | KMT2ATDP1MEN1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642997-A1 | ZINC-BASED SULFUR COMPOUND SCAVENGER WITH REDUCED SOLIDS DEPOSITION | Baker Hughes Oilfield Operations LLC (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12343335-B2 | Pharmaceutical composition for treating multiple sclerosis on basis of AMPK inhibitory function and zinc homeostasis control function | ZINCURE CORP. (KR) | 2025-07-01 | — | — | US | disclosed |
| CN-119505252-A | Organometallic framework ultrasound contrast agent for activating tumor immunity and preparation method and application thereof | 山东大学齐鲁医院 | 2025-02-25 | — | — | CN | disclosed |
| WO-2024145404-A1 | ZINC-BASED SULFUR COMPOUND SCAVENGER WITH REDUCED SOLIDS DEPOSITION | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2024-07-04 | — | — | WO | disclosed |
| US-20240218273-A1 | ZINC-BASED SULFUR COMPOUND SCAVENGER WITH REDUCED SOLIDS DEPOSITION | BAKER HUGHES OILFIELD OPERATIONS LLC (US) | 2024-07-04 | — | — | US | disclosed |
| WO-2024112438-A1 | POLYUNSATURATED FATTY ACID-BOUND ALPHA FETOPROTEIN PROMOTES IMMUNE SUPPRESSION BY ALTERING HUMAN DENDRITIC CELL METABOLISM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-05-30 | — | — | WO | disclosed |
| CN-116710467-A | Photooxidation reduction protein modification | 罗莎琳德·富兰克林研究所 | 2023-09-05 | — | — | CN | disclosed |
| US-11649228-B2 | Zinc indicators for cellular imaging | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-05-16 | — | — | US | disclosed |
| US-20230000839-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING MULTIPLE SCLEROSIS ON BASIS OF AMPK INHIBITORY FUNCTION AND ZINC HOMEOSTASIS CONTROL FUNCTION | ZINCURE CORP. (KR) | 2023-01-05 | — | — | US | disclosed |
| EP-4066832-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING MULTIPLE SCLEROSIS ON BASIS OF AMPK INHIBITORY FUNCTION AND ZINC HOMEOSTASIS CONTROL FUNCTION | Zincure Corp. (KR) | 2022-10-05 | — | — | EP | disclosed |
| CN-114929217-A | Pharmaceutical composition for treating multiple sclerosis based on AMPK inhibitory function and zinc homeostasis control function | 锌医疗公司 | 2022-08-19 | — | — | CN | disclosed |
| WO-2022118054-A1 | RED FLUORESCENT SENSOR COMPOUNDS FOR THE DETECTION OF METAL IONS | FEMTONICS KFT. (HU) | 2022-06-09 | — | — | WO | disclosed |
| CN-109952297-B | Compound (I) | 奥斯陆大学 | 2022-02-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230000839-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING MULTIPLE SCLEROSIS ON BASIS OF AMPK INHIBITORY FUNCTION AND ZINC HOMEOSTASIS CONTROL FUNCTION | PRKAB1, PRKAB2, PRKAG1 | KMT2A 2170/4885TDP1 4228/4885MEN1 3953/4885 |
| US-11649228-B2 | Zinc indicators for cellular imaging | IAPP, SLC30A6, SLC30A7 | KMT2A 4760/4885TDP1 3228/4885MEN1 2196/4885 |
| US-12343335-B2 | Pharmaceutical composition for treating multiple sclerosis on basis of AMPK inhibitory function and zinc homeostasis control function | PRKAB1, PRKAB2, PRKAG1 | KMT2A 2170/4885TDP1 4228/4885MEN1 3953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.